Healthcare sector | Medical Devices industry
| Price | $13.05 |
|---|---|
| Shares Outstanding | 46.51M |
| All-Time Low | $9.30 |
| 52-Week Low | $9.30 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $1.29 |
| Net Tangible Assets / Share | $5.71 |
| Shares Outstanding Ave Change (Annual) | -1.58% |
| Shares Δ YoY | -0.46% |
| Avg CA Burn (Annual %) | 1.59% (as of 3-8-2026) |
| Avg CA Burn (Quarterly %) | -2.39% (as of 3-8-2026) |
| Max Earning Power / Share | $2.66 |
|---|---|
| Adjusted Earning Power |
$-0.27
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.56%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 34.4M (as of 3-8-2026) |
| Avg EBITDA (5Q) | 8.9M (as of 3-8-2026) |
| Avg Net Income (5Y) | -99.3M (as of 3-8-2026) |
| Avg Net Income (5Q) | -94M (as of 3-8-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-8-2026 |
| Consecutive Years Paid | No | 3-8-2026 |
| Pays Dividend | No | 3-8-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 3-8-2026 |
| Net Income Positive | No | 3-8-2026 |
| Current Dividend Streak | No | 3-8-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $5.72 | 265.5M ($265,500,000) | 46.5M (46,456,462) |
| 2025-09-30 | Quarterly | $5.64 | 261.6M ($261,600,000) | 46.4M (46,416,998) |
| 2025-06-30 | Quarterly | $6.26 | 289.7M ($289,700,000) | 46.3M (46,314,057) |
| 2025-03-31 | Quarterly | $5.98 | 276.3M ($276,300,000) | 46.2M (46,236,444) |
| 2024-12-31 | Quarterly | $5.67 | 260.6M ($260,600,000) | 46M (45,962,627) |
| 2024-12-31 | Annual | $5.67 | 260.6M ($260,600,000) | 46M (45,962,627) |
| 2024-09-30 | Quarterly | $4.67 | 214.5M ($214,500,000) | 46M (45,954,931) |
| 2023-12-31 | Annual | $4.35 | 200.7M ($200,700,000) | 46.2M (46,174,337) |
| 2022-12-31 | Annual | $6.38 | 296.7M ($296,700,000) | 46.5M (46,528,907) |
| 2021-12-31 | Annual | $6.80 | 327.8M ($327,800,000) | 48.2M (48,206,156) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 687.8M ($687,800,000) |
| 2023-12-31 | 673.3M ($673,300,000) |
| 2022-12-31 | 684.1M ($684,100,000) |
| 2021-12-31 | 587M ($587,000,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-19 | 46,507,755 | +4,297 |
| 2026-03-04 | 46,503,458 | +84,551 |
| 2025-11-07 | 46,418,907 | +16,426 |
| 2025-09-17 | 46,402,481 | -19 |
| 2025-08-06 | 46,402,500 | +158,500 |
Latest short-interest change: 2,607,300 shares (7.94% of float) | Days to cover: 4.22
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-11 | 2,607,300 shares | -347,525 | -11.76% |
| 2026-02-26 | 2,954,825 shares | -454,787 | -13.34% |
| 2026-02-11 | 3,409,612 shares | +191,188 | +5.94% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.